34 citations as recorded by crossref.

1. Suppressive Antibiotic Treatment in Prosthetic Joint Infections: A Perspective J. Cobo & R. Escudero-Sanchez
2. Antibiotics with antibiofilm activity – rifampicin and beyond L. Ferreira et al.
3. Dosing and treatment duration of suppressive antimicrobial therapy in orthopedic implant infections: a cohort study J. Hanssen et al.
4. Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice M. Gatti et al.
5. Long-Term Outcomes Following Suppressive Antibiotic Therapy: A 10-Year Cohort Study R. George et al.
6. Diagnosis and management of infected arthroplasty T. Pannu et al.
7. Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety A. Ruiz-Sancho et al.
8. Reinfection and re-revision rates of 113 two-stage revisions in infected TKA J. Bongers et al.
9. Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from Periprosthetic Joint Infections J. Chen et al.
10. Safety of Longer-Term Doxycycline Use: A Systematic Review and Meta-Analysis With Implications for Bacterial Sexually Transmitted Infection Chemoprophylaxis P. Chan et al.
11. Prevention and antibiotic therapy of hip periprosthetic joint infections F. GIOVANNENZE et al.
12. Results of Aspiration, Erythrocyte Sedimentation Rate, and C-Reactive Protein in Patients With Known Prosthetic Joint Infection on Chronic Suppression M. Benson et al.
13. Oral tetracyclines for bone and joint infections: what do we know? T. Cartau et al.
14. Periprosthetic Joint Infection R. Miller et al.
15. Rôle des CRIOAC : quand faire appel à un CRIOAC ? Stratégie thérapeutique, principes de l’antibiothérapie H. Migaud et al.
16. Periprosthetic joint infection after arthroplasty: advances and future prospects X. Xiong et al.
17. Efficacy and Safety of Tetracyclines in Bone and Joint Infections: A Literature Review P. Laffont-Lozes et al.
18. Biofilm and How It Relates to Prosthetic Joint Infection A. MacConnell et al.
19. Role of Tetracyclines in Joint Arthroplasties K. Passadi et al.
20. Global practice variation of suppressive antimicrobial treatment for prosthetic joint infections: A cross-sectional survey study J. Hanssen et al.
21. Long-Term Impact of Suppressive Antibiotic Therapy on Intestinal Microbiota R. Escudero-Sánchez et al.
22. Outcomes of Long-Term Antibiotic Therapy for Prosthetic Joint Infection: A Cohort Study in a Canadian High-Volume Arthroplasty Center C. Righolt et al.
23. Clinical use of linezolid in periprosthetic joint infections – a systematic review C. Theil et al.
24. The Application of Suppressive Antibiotic Therapy for Implant-Related Infection X. Wu et al.
25. Implant-Associated Infection of Long-Segment Spinal Instrumentation: A Retrospective Analysis of 46 Consecutive Patients S. Oikonomidis et al.
26. The Use of Long-term Antibiotics for Suppression of Bacterial Infections M. Horne et al.
27. Resektionsarthroplastik und Arthrodese in der Prothesenrevision O. Somberg et al.
28. Polymicrobial periprosthetic joint infections of the hip and knee D. Margaryan et al.
29. Long-Term Outcomes in Patients on Life-Long Antibiotics: A Five-Year Cohort Study C. Kiss et al.
30. 2025 ICM: Antimicrobial Therapy Options in Special Circumstances M. Karim et al.
31. Debridement, antibiotics and implant retention: are all approaches to periprosthetic joint infection equal? Same procedures, different outcomes P. Sendi et al.
32. Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin P. Reinecke et al.
33. Complications of Hip Hemiarthroplasty G. Domingue et al.
34. Suppressive Antibiotic Therapy in Prosthetic Joint Infections: A Contemporary Overview H. Harrabi et al.